Bright Minds Biosciences Inc
(DRUG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Operating Expenses | 9,964 | 2,075 | 5,477 | 11,724 | 6,954 |
| Operating Income | -9,964 | -2,075 | -5,477 | -11,724 | -6,954 |
| Other Income | 1,221 | 15 | 11 | 8 | 107 |
| Pre-tax Income | -8,743 | -2,059 | -5,467 | -11,716 | -6,847 |
| Net Income Continuous | -8,743 | -2,059 | -5,467 | -11,716 | -6,847 |
| Net Income | $-8,743 | $-2,059 | $-5,467 | $-11,716 | $-6,847 |
| EPS Basic Total Ops | -1.27 | -0.48 | -1.47 | -4.74 | -3.82 |
| EPS Basic Continuous Ops | -1.27 | -0.48 | -1.47 | -4.74 | -3.82 |
| EPS Diluted Total Ops | -1.27 | -0.48 | -1.47 | -4.74 | -3.82 |
| EPS Diluted Continuous Ops | -1.27 | -0.48 | -1.47 | -4.74 | -3.82 |
| EPS Diluted Before Non-Recurring Items | -1.27 | -0.48 | -1.47 | -4.75 | -3.80 |
| EBITDA(a) | $-9,909 | $-2,021 | $-5,423 | $-11,719 | $-6,954 |